Clinical Trials Logo

Seizures clinical trials

View clinical trials related to Seizures.

Filter by:

NCT ID: NCT00141388 Completed - Clinical trials for Seizure Disorder, Partial

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures

Start date: July 1998
Phase: Phase 3
Study type: Interventional

To evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.

NCT ID: NCT00141336 Completed - Clinical trials for Seizure Disorder, Partial

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Start date: November 1999
Phase: Phase 3
Study type: Interventional

To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.

NCT ID: NCT00141258 Completed - Partial Seizures Clinical Trials

Pregabalin Epilepsy Add-On Trial

Start date: October 2005
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy of pregabalin as adjunctive therapy, using a flexible, optimized dose schedule with dose adjustment based on clinical response and tolerability, compared to placebo in subjects with partial seizures

NCT ID: NCT00141245 Completed - Clinical trials for Seizure Disorder, Partial

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Start date: October 1998
Phase: Phase 3
Study type: Interventional

To evaluate long-term safety and efficacy of pregabalin in patients with partial seizures.

NCT ID: NCT00116064 Completed - Status Epilepticus Clinical Trials

Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions

Start date: July 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate intranasal lorazepam in paediatric status epilepticus. This is a potentially, more effective, safer and cheaper treatment for a common paediatric medical emergency compared to our present first line therapy intramuscular paraldehyde.

NCT ID: NCT00113815 Completed - Epilepsy Clinical Trials

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Start date: May 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the tolerability, safety and efficacy of topiramate in infants with refractory partial onset seizures (POS).

NCT ID: NCT00113165 Completed - Epilepsy Clinical Trials

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Start date: October 2004
Phase: Phase 3
Study type: Interventional

This study is being conducted to compare the efficacy and safety of LAMICTAL (lamotrigine) extended-release with placebo in the treatment of partial seizures. LAMICTAL extended-release is an investigational drug. Placebo tablets look like LAMICTAL extended-release tablets but do not contain active medication. In this study, LAMICTAL extended-release or placebo tablets will be added to current seizure treatments.

NCT ID: NCT00104416 Completed - Epilepsy Clinical Trials

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures

Start date: December 2004
Phase: Phase 3
Study type: Interventional

This study is being conducted to compare the efficacy and safety of LAMICTAL (lamotrigine) extended-release with placebo in the treatment of Primary Generalized Tonic-Clonic (PGTC) seizures. LAMICTAL extended-release is an investigational drug. Placebo tablets look like LAMICTAL extended-release tablets but do not contain active medication. In this study, LAMICTAL extended-release or placebo tablets will be added to current seizure treatments.

NCT ID: NCT00102713 Completed - Partial Seizures Clinical Trials

A Study for Treatment of Partial Seizures in Children

Start date: February 2005
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the safety profile of the investigational medication, Depakote Sprinkle Capsules, in the treatment of partial seizures in children ages 3-10.

NCT ID: NCT00088452 Completed - Epilepsy Clinical Trials

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

Start date: July 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.